Roche (OTCMKTS:RHHBY) Stock Gets Downgrade from UBS Group

Roche (OTCMKTS:RHHBY) was downgraded by research analysts at UBS Group from a “strong-buy” rating to a “hold” rating in a report issued on Monday, Zacks reports.

A number of other equities research analysts also recently issued reports on the stock. Deutsche Bank Aktiengesellschaft upgraded shares of Roche from a “hold” rating to a “buy” rating in a research report on Friday, October 23rd. Morgan Stanley upgraded shares of Roche from an “equal weight” rating to an “overweight” rating and set a $63.00 price target on the stock in a report on Friday, August 7th. Zacks Research raised shares of Roche from a “strong sell” rating to a “hold” rating in a research note on Monday, August 24th. HSBC reiterated a “hold” rating on shares of Roche in a report on Thursday, September 10th. Finally, Oddo Bhf raised Roche to an “outperform” rating in a research report on Tuesday, October 20th. Eight investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $60.00.

Roche Price Performance

RHHBY stock opened at $59.18 on Monday. The firm has a 50 day simple moving average of $55.70 and a 200 day simple moving average of $53.80. Roche has a 52 week low of $40.25 and a 52 week high of $61.49. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.95 and a current ratio of 1.23.

Hedge Funds Weigh In On Roche

Several hedge funds and other institutional investors have recently added to or reduced their stakes in RHHBY. McIlrath & Eck LLC acquired a new stake in Roche in the first quarter valued at approximately $39,000. Renasant Bank acquired a new position in shares of Roche during the 2nd quarter worth $210,000. Woodstock Corp acquired a new position in shares of Roche during the 3rd quarter worth $245,000. Enterprise Financial Services Corp increased its stake in shares of Roche by 6.6% during the 1st quarter. Enterprise Financial Services Corp now owns 5,576 shares of the company’s stock worth $277,000 after purchasing an additional 345 shares during the last quarter. Finally, Archer Investment Corp raised its holdings in shares of Roche by 7.7% during the 1st quarter. Archer Investment Corp now owns 5,598 shares of the company’s stock valued at $278,000 after purchasing an additional 398 shares in the last quarter.

About Roche

Roche Holding AG is a Switzerland-based healthcare company focused on pharmaceuticals and diagnostics. Founded in 1896 and headquartered in Basel, Roche develops medicines and diagnostic technologies intended to support the prevention, diagnosis and treatment of serious diseases.

The company’s pharmaceutical business concentrates on areas including oncology, immunology, neuroscience, ophthalmology and hematology. Its products include targeted cancer therapies, treatments for multiple sclerosis and hemophilia, and medicines for other specialized conditions.